Notice2021-17523
Agency Information Collection Activities: Proposed eCollection, eComments Requested; Reinstatement of a Discontinued Collection: Recordkeeping for Electronic Prescriptions for Controlled Substances
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 17, 2021
Issuing agencies
Justice Department
Abstract
The Drug Enforcement Administration (DEA), Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 156 (Tuesday, August 17, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 156 (Tuesday, August 17, 2021)]
[Notices]
[Pages 46016-46017]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-17523]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[OMB Number 1117-0049]
Agency Information Collection Activities: Proposed eCollection,
eComments Requested; Reinstatement of a Discontinued Collection:
Recordkeeping for Electronic Prescriptions for Controlled Substances
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 60-Day notice.
-----------------------------------------------------------------------
SUMMARY: The Drug Enforcement Administration (DEA), Department of
Justice (DOJ), will be submitting the following information collection
request to the Office of Management and Budget (OMB) for review and
approval in accordance with the Paperwork Reduction Act of 1995.
DATES: Comments are encouraged and will be accepted for 60 days until
October 18, 2021.
FOR FURTHER INFORMATION CONTACT: If you have comments on the estimated
public burden or associated response time, suggestions, or need a copy
of the proposed information collection instrument with instructions or
additional information, please contact Scott A. Brinks, Diversion
Control Division, Drug Enforcement Administration; Mailing Address:
8701 Morrissette Drive, Springfield, Virginia 22152; Telephone: (571)
362-3261.
SUPPLEMENTARY INFORMATION: Written comments and suggestions from the
public and affected agencies concerning the proposed collection of
information are encouraged. Your comments should address one or more of
the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other forms of information technology, e.g.,
permitting electronic submission of responses.
[[Page 46017]]
Overview of This Information Collection
1. Type of Information Collection: Reinstatement of a discontinued
collection.
2. Title of the Form/Collection: Recordkeeping for Electronic
Prescriptions for Controlled Substance.
3. The agency form number, if any, and the applicable component of
the Department sponsoring the collection: There is no form number. The
applicable component within the Department of Justice is the Drug
Enforcement Administration, Diversion Control Division.
4. Affected public who will be asked or required to respond, as
well as a brief abstract:
Affected public (Primary): Business or other for-profit.
Affected public (Other): Not-for-profit institutions; Federal,
State, local, and tribal governments.
Abstract: DEA is requiring that each registered practitioner apply
to an approved credential service provider approved to obtain identity
proofing and a credential. Hospitals and other institutional
practitioners may conduct this process in-house as part of their
credentialing. For practitioners currently working at or affiliated
with a registered hospital or clinic, the hospital/clinic have to check
a government-issued photographic identification. This may be done when
the hospital/clinic issues credentials to new hires or newly affiliated
physicians. For individual practitioners, two people need to enter
logical access control data to grant permissions for practitioners
authorized to approve and sign controlled substance prescriptions using
the electronic prescription application. For institutional
practitioners, logical access control data is entered by two people
from an entity within the hospital/clinic that is separate from the
entity that conduct identity proofing in-house. Similarly, pharmacies
have to set logical access controls in the pharmacy application so that
only authorized employees have permission to annotate or alter
prescription records. Finally, if the electronic prescription or
pharmacy application generates an incident report, practitioners,
hospitals/clinics, and pharmacies have to review the incident report to
determine if the event identified by the application represents a
security incident.
5. An estimate of the total number of respondents and the amount of
time estimated for an average respondent to respond: The below table
presents information regarding the number of respondents, hour burden
per responses and associated burden hours.
----------------------------------------------------------------------------------------------------------------
Number of Hour burden
respondents per response Burden hours
----------------------------------------------------------------------------------------------------------------
Practitioners................................................... 78,164 0.67 52,370
MLP............................................................. 49,067 0.67 32,875
Hospital/Clinics................................................ 1,482 2.13 3,157
Pharmacies...................................................... 3,984 0.33 1,315
-----------------------------------------------
Total....................................................... 132,697 .............. 89,717
----------------------------------------------------------------------------------------------------------------
6. An estimate of the total public burden (in hours) associated
with the proposed collection: DEA estimates that this collection takes
89,717 annual burden hours.
If additional information is required please contact: Melody
Braswell, Department Clearance Officer, United States Department of
Justice, Justice Management Division, Policy and Planning Staff, Two
Constitution Square, 145 N Street NE, Suite 3E.405B, Washington, DC
20530.
Dated: August 11, 2021.
Melody Braswell,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2021-17523 Filed 8-16-21; 8:45 am]
BILLING CODE 4410-09-P
</pre></body>
</html>Indexed from Federal Register on August 17, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.